Literature DB >> 7216493

HeLa cell infection by Yersinia enterocolitica: evidence for lack of intracellular multiplication and development of a new procedure for quantitative expression of infectivity.

J A Devenish, D A Schiemann.   

Abstract

The in vitro invasive properties of bacteria have frequently been studied by the use of HeLa cell cultures in chamber slides, using microscopic examination to enumerate intracellular bacteria. When this system was used to examine invasive properties of Yersinia enterocolitica, it resulted in rapid internalization of high numbers of bacteria during the infection phase which prevented subsequent discrimination of intracellular multiplication. A modified procedure was developed which standardized the ratio of bacteria to HeLa cells (i.e., multiplicity), the time for the infection phase, and the addition of specific antiserum with gentamicin for restricting bacterial uptake during the intracellular growth phase. Studies with this modified chamber slide system found that strains of human isolates of Y. enterocolitica (serotypes O:3, O:8, O:5,27, and O:6,30) exhibited different degrees of cell infection but did not multiply intracellularly. A second test system was developed that used roller tubes and viable cell counts for the enumeration of intracellular bacteria. This roller tube system confirmed that internalized bacteria did not multiply inside HeLa cells over a 24-h period. The roller tube system with viable cell counts for enumeration is a simplified technique for quantitative comparison of in vitro infectivity of HeLa cells by Y. enterocolitica.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216493      PMCID: PMC350585          DOI: 10.1128/iai.32.1.48-55.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Studies on the pathogenicity of Yersinia enterocolitica. II. Interaction with cultured cells in vitro.

Authors:  T Une
Journal:  Microbiol Immunol       Date:  1977       Impact factor: 1.955

2.  Microbiological methods. Problems in the recovery and identification of Yersinia from food.

Authors:  I J Mehlman; C C Aulisio; A C Sanders
Journal:  J Assoc Off Anal Chem       Date:  1978-07

3.  Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella.

Authors:  R A Giannella; O Washington; P Gemski; S B Formal
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Yersinia enterocolitica: in vitro antimicrobial susceptibility.

Authors:  M Raevuori; S M Harvey; M J Pickett; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Shigella infection of henle intestinal epithelial cells: role of the host cell.

Authors:  T L Hale; R E Morris; P F Bonventre
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

6.  Yersinia enterocolitica isolates from humans in California, 1968-1975.

Authors:  M L Bissett
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

7.  Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes.

Authors:  P Vaudaux; F A Waldvogel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Growth of shigellae in monolayer tissue cultures.

Authors:  D F GERBER; H M WATKINS
Journal:  J Bacteriol       Date:  1961-12       Impact factor: 3.490

9.  ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.

Authors:  S B FORMAL; E H LABREC; T H KENT; S FALKOW
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

10.  Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells.

Authors:  C C SHEPARD
Journal:  J Exp Med       Date:  1957-01-01       Impact factor: 14.307

View more
  37 in total

1.  A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association.

Authors:  P Dersch; R R Isberg
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  The integrin-binding domain of invasin is sufficient to allow bacterial entry into mammalian cells.

Authors:  S Rankin; R R Isberg; J M Leong
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product.

Authors:  V L Miller; J B Bliska; S Falkow
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

4.  Factors contributing to the reduced invasiveness of chlorine-injured Yersinia enterocolitica.

Authors:  M W LeChevallier; D A Schiemann; G A McFeters
Journal:  Appl Environ Microbiol       Date:  1987-06       Impact factor: 4.792

5.  Yersinia enterocolitica and related species isolated from wildlife in New York State.

Authors:  M Shayegani; W B Stone; I DeForge; T Root; L M Parsons; P Maupin
Journal:  Appl Environ Microbiol       Date:  1986-09       Impact factor: 4.792

6.  Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection.

Authors:  S M Fleiszig; T S Zaidi; E L Fletcher; M J Preston; G B Pier
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  An enterotoxin-negative strain of Yersinia enterocolitica serotype O:3 is capable of producing diarrhea in mice.

Authors:  D A Schiemann
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Translocation of Yersinia enterocolitica through an endothelial monolayer by polymorphonuclear leukocytes.

Authors:  H Rüssmann; K Ruckdeschel; J Heesemann
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Infection caused by Yersinia enterocolitica serotype O:21.

Authors:  M A Karmali; S Toma; D A Schiemann; S H Ein
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

10.  Recombinant Escherichia coli clones expressing Chlamydia trachomatis gene products attach to human endometrial epithelial cells.

Authors:  D H Schmiel; S T Knight; J E Raulston; J Choong; C H Davis; P B Wyrick
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.